NCT00718562 - Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG

AMN107

Trial Locations (8)

Novartis Investigative Site, Nagoya

Novartis Investigative Site, Kashiwa

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Sapporo

Novartis Investigative Site, Niigata

Novartis Investigative Site, Suita

Novartis Investigative Site, Sunto-gun

Novartis Investigative Site, Chuo-ku